Critical Shortage of Medication for ALL and Osteosarcoma: You Can Help


As you may have heard through recent national news stories, there is currently a significant shortage of the chemotherapy medication preservative-free methotrexate in the United States. This drug is critical to the treatment of children with acute lymphoblastic leukemia (ALL) and osteosarcoma. Unless production of preservative-free methotrexate increases, hospitals will run out of the medication completely in the days and weeks ahead.

YOU CAN HELP IN TWO WAYS 

Contact the following pharmaceutical companies who produce methotrexate and ask them to:

  1. Prioritize the production of the preservative-free form of methotrexate. 
  2. Consider working with the FDA to import preservative-free methotrexate if sources are available. 
Hospira, Inc. Customer Service 1-877-946-7747
Mylan Institutional 1-888-258-4199
Sandoz Customer Service 1-609-627-8500

Second, contact your Representatives and Senators on Capitol Hill and ask them to immediately send a letter to these same pharmaceutical companies requesting that they:

  1. Prioritize the production of the preservative-free form of methotrexate.
  2. Consider working with the FDA to import preservative-free methotrexate if sources are available.

To send a letter to your representative, click here.

Thank you for your support of this important issue! 

Christine Bork
Email Christine
(240) 235-2208



Childhood Cancer

Medical Information

Research

Coping with Cancer

Get Involved

About Us